Application of click chemistry for signal amplification in IHC and ISH assays

US11249085B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11249085-B2
Application numberUS-201816226489-A
CountryUS
Kind codeB2
Filing dateDec 19, 2018
Priority dateJun 28, 2016
Publication dateFeb 15, 2022
Grant dateFeb 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Applicants have developed an amplification system and methodology for IHC and ISH staining that utilizes “click chemistry” to covalently bind reporter molecules to tissue.

First claim

Opening claim text (preview).

The invention claimed is: 1. A conjugate having Formula (III): A Linker M  (III), wherein M is a cinnamic acid moiety or a compound having Formula (111a), wherein each R group is independently selected from hydrogen or a lower alkyl group having between 1 and 4 carbon atoms; wherein the cinnamic acid moiety is covalently coupled to the ‘Linker’ via the carboxylic acid group of the cinnamic acid moiety, and wherein the compound having Formula (111a) is covalently coupled to the ‘Linker’ via the amino moiety of the compound having Formula (111a); A is a dibenzocyclooctyne; and ‘Linker’ is a branched or unbranched, linear or cyclic, substituted or unsubstituted, saturated or unsaturated, group having between 2 and 80 carbon atoms, and optionally having one or more heteroatoms selected from O, N, or S. 2. The conjugate of claim 1 , wherein ‘Linker’ has the formula (Ia) wherein d and e are integers each independently ranging from 2 to 20; t and u are independently 0 or 1; Q is a bond, O, S, or N(R c )(R d ); R a and R b are independently H, a C 1 -C 4 alkyl group, F, Cl, or N(R c )(R d ); R c and R d are independently CH 3 or H; and X and Y are independently a branched or unbranched, linear or cyclic, substituted or unsubstituted, saturated or unsaturated group having between 1 and 12 carbon atoms and optionally having one or more O, N, or S heteroatoms. 3. The conjugate of claim 1 , wherein R a and R b are each hydrogen. 4. The conjugate of claim 2 , wherein Q is oxygen. 5. The conjugate of claim 1 , wherein R a and R b are each hydrogen, Q is oxygen, and e ranges from 2 to 10. 6. The conjugate of claim 1 , wherein the Linker comprises one or more alkylene oxide groups. 7. The conjugate of claim 1 , wherein the Linker comprises at least three PEG groups. 8. The conjugate of claim 1 , wherein the Linker comprises five PEG groups. 9. The conjugate of claim 1 , wherein A comprises dibenzocyclooctyne and the Linker comprises at least three PEG groups. 10. The conjugate of claim 1 , wherein the Linker comprises at least three PEG groups and at least two carbonyl groups. 11. The conjugate of claim 1 , wherein A comprises dibenzocyclooctyne and wherein the Linker is water soluble. 12. The conjugate of claim 1 , wherein the conjugate is 13. A conjugate having Formula (III): A Linker M  (III), wherein M is a compound having Formula (111a), wherein each R group is independently selected from hydrogen or lower alkyl group having between 1 and 4 carbon atoms, wherein said ‘M is covalently coupled to the ‘Linker’ via the amino moiety of the compound having the Formula (111a); A is a dibenzocyclooctyne; and ‘Linker’ is a branched or unbranched, linear or cyclic, substituted or unsubstituted, saturated or unsaturated, group having between 2 and 80 carbon atoms, and optionally having one or more heteroatoms selected from O, N, or S. 14. The conjugate of claim 13 , wherein the Linker comprises at least three alkylene oxide groups. 15. The conjugate of claim 13 , wherein the Linker comprises at least five alkylene oxide groups. 16. The conjugate of claim 14 , wherein the Linker further comprises at least two carbonyl groups. 17. The conjugate of claim 16 , wherein at least one R group comprises H. 18. A conjugate having Formula (III): A Linker M  (III), wherein M is a compound having any one of Formulas (111c) or (111d), wherein each R group is independently selected from hydrogen or lower alkyl group having between 1 and 4 carbon atoms, wherein the compound having any one of Formulas (111c) or (111d) is covalently coupled to the ‘Linker’ via the carboxylic acid of the compound having any one of the Formulas (111c) of (111d); A is a dibenzocyclooctyne; and ‘Linker’ is a branched or unbranched, linear or cyclic, substituted or unsubstituted, saturated or unsaturated, group having between 2 and 80 carbon atoms, and optionally having one or more heteroatoms selected from O, N, or S.

Assignees

Inventors

Classifications

  • condensed with carbocyclic rings or carbocyclic ring systems · CPC title

  • G01N33/582Primary

    with fluorescent label · CPC title

  • having four or more nitrogen atoms as the only ring hetero atoms · CPC title

  • with hydroxyaryl compounds · CPC title

  • condensed with carbocyclic rings or ring systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11249085B2 cover?
Applicants have developed an amplification system and methodology for IHC and ISH staining that utilizes “click chemistry” to covalently bind reporter molecules to tissue.
Who is the assignee on this patent?
Ventana Med Syst Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/582. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).